Bharat Biotech to manufacture 2 crore doses of Covaxin at UP's Bulandshahr plant every month
As states face an acute shortage of COVID-19 vaccines, the central government on Wednesday (May 12, 2021) approved the proposal of Bharat Biotech to set up a new plant of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh’s Bulandshahr.
May 13, 2021, 08:22 AM IST
Here’s how much it will cost to vaccinate all above 18 in India?
As per Ind-Ra’s calculations, vaccinating the targeted group may cost Rs 671.93 billion, of which the Union government is expected to spend Rs 208.70 billion and state governments together will incur Rs 463.23 billion. As a result, Indian vaccine manufacturers would now be supplying 50 percent of their production to the Indian government and the balance 50 percent would be available for procurement by the state governments and the open market.
Apr 23, 2021, 21:16 PM IST
